Differentially methylated sequences in pancreatic cancer

Details Differentially methylated sequences in pancreatic cancer Differentially methylated sequences in pancreatic cancer

2006-12-26

2006-12-26

Benzion, Gary (Department: 1637)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

07153653

ABSTRACT:
The present invention provides a method for detecting a cellular proliferative disorder in a subject. The method includes contacting a nucleic acid-containing specimen from the subject with an agent that provides a determination of the methylation state of at least one gene or associated regulatory region of the gene and identifying aberrant methylation of regions of the gene or regulatory region, wherein aberrant methylation is identified as being different when compared to the same regions of the gene or associated regulatory region in a subject not having said cellular proliferative, thereby detecting a cellular proliferative disorder in the subject.

REFERENCES:
patent: 5552277 (1996-09-01), Nelson et al.
patent: 5756668 (1998-05-01), Baylin et al.
patent: 5856094 (1999-01-01), Sidransky et al.
patent: 5871917 (1999-02-01), Duffy
patent: 6251594 (2001-06-01), Gonzalgo et al.

Affiliated with

Also associated with

Rating

Differentially methylated sequences in pancreatic cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Differentially methylated sequences in pancreatic cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Differentially methylated sequences in pancreatic cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3656019